Literature DB >> 23292052

Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation.

Filippo Ansaldi1, Daniela de Florentiis, Paola Canepa, Antonella Ceravolo, Emanuela Rappazzo, Rocco Iudici, Mariano Martini, Gerardo Botti, Andrea Orsi, Giancarlo Icardi, Paolo Durando.   

Abstract

A serial cross-sectional study of nasopharyngeal carriage among adults aged 60 y or over was conducted in winter-spring 2012 with the aim to describe circulating Streptococcus pneumoniae in an area, Liguria Administrative Region, where the vaccine was implemented for a decade and coverage in pediatric age group reached a value close to 100% for more than 5 y, determining a picture of very high vaccine immunological pressure. The serotype-specific carriage picture in adults was compared with that observed in children by means of a cross-sectional study performed one year before using the same sampling and laboratory methods.   Cluster sampling enrolled 283 adults, representative of the open population. Detection of multi-serotype carriage was performed using, real-time PCR and primer specific PCRs. Carriage prevalence of participants with at least one positive sample adjusted for age, i.e., period prevalence, was 18.7%, considering the Ligurian population as standard population, showing that the pneumococcal carriage in the elderly is not a rare event as emerged in other surveys. The long-term use of PCV7 has resulted in strong decrease of vaccine types carriage among adults and children. A multivariate analysis showed that age class and contact with children attending day care covariates were strongly associated with Streptococcus pneumoniae carriage. A strong link between the picture observed in < 5-y-old children and ≥ 60-y-old adults emerged: a strong correlation of specific-serotype prevalence between adults and children and risk factor analysis supported the role played by inter-age-group transmission.

Entities:  

Keywords:  S. pneumoniae; carriage; conjugate vaccine; replacement; vaccine prevention

Mesh:

Substances:

Year:  2013        PMID: 23292052      PMCID: PMC3891719          DOI: 10.4161/hv.23253

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  22 in total

1.  Potential nonpneumococcal confounding of PCR-based determination of serotype in carriage.

Authors:  Maria da Gloria Carvalho; Godfrey M Bigogo; Muthoni Junghae; Fabiana C Pimenta; Iaci Moura; Alexis Roundtree; Zhongya Li; Laura Conklin; Daniel R Feikin; Robert F Breiman; Cynthia G Whitney; Bernard Beall
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

2.  Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates.

Authors:  Rekha Pai; Robert E Gertz; Bernard Beall
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007.

Authors:  H De Carvalho Gomes; M Muscat; D L Monnet; J Giesecke; P L Lopalco
Journal:  Euro Surveill       Date:  2009-03-26

4.  Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.

Authors:  Laura L Hammitt; Dana L Bruden; Jay C Butler; Henry C Baggett; Debby A Hurlburt; Alisa Reasonover; Thomas W Hennessy
Journal:  J Infect Dis       Date:  2006-04-27       Impact factor: 5.226

5.  Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

Authors:  Gerwin D Rodenburg; Sabine C de Greeff; Angelique G C S Jansen; Hester E de Melker; Leo M Schouls; Eelko Hak; Lodewijk Spanjaard; Elisabeth A M Sanders; Arie van der Ende
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

6.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

7.  Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Authors:  Steven Black; Henry Shinefield; Roger Baxter; Robert Austrian; Laura Bracken; John Hansen; Edwin Lewis; Bruce Fireman
Journal:  Pediatr Infect Dis J       Date:  2004-06       Impact factor: 2.129

8.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

9.  Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy.

Authors:  Paolo Durando; Pietro Crovari; Filippo Ansaldi; Laura Sticchi; Camilla Sticchi; Valter Turello; Lorenzo Marensi; Raffaella Giacchino; Anna Timitilli; Roberto Carloni; Chiara Azzari; Giancarlo Icardi
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

Review 10.  Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.

Authors:  Markus Rose; Stefan Zielen
Journal:  Expert Rev Vaccines       Date:  2009-10       Impact factor: 5.217

View more
  13 in total

1.  Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23.

Authors:  David S Fedson
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

2.  Effect of Oral Streptococci Expressing Pneumococcus-like Cross-Reactive Capsule Types on World Health Organization Recommended Pneumococcal Carriage Detection Procedure.

Authors:  Feroze Ganaie; Angela R Branche; Michael Peasley; Jason W Rosch; Moon H Nahm
Journal:  Clin Infect Dis       Date:  2022-09-10       Impact factor: 20.999

3.  Safety and tolerability of 13-valent pneumococcal conjugate vaccine in the elderly.

Authors:  Paolo Durando; Roberto Rosselli; Ilaria Cremonesi; Andrea Orsi; Erika Albanese; Ilaria Barberis; Chiara Paganino; Cecilia Trucchi; Mariano Martini; Lorenzo Marensi; Valter Turello; The Ligurian Pneumococcal Study Group; Alessandro Bregante; Roberto Cacciani; Rocco Iudici; Diego La Marca; Leonardo Pedano; Amadio Franco Petrucci; Maria Santolini; Valentina Sbisà; Monica Zacconi
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 4.  Pneumococcal Capsular Polysaccharide Immunity in the Elderly.

Authors:  Hugh Adler; Daniela M Ferreira; Stephen B Gordon; Jamie Rylance
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

5.  The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition.

Authors:  Amelieke Jh Cremers; Aldert L Zomer; Jenna F Gritzfeld; Gerben Ferwerda; Sacha Aft van Hijum; Daniela M Ferreira; Joshua R Shak; Keith P Klugman; Jos Boekhorst; Harro M Timmerman; Marien I de Jonge; Stephen B Gordon; Peter Wm Hermans
Journal:  Microbiome       Date:  2014-12-15       Impact factor: 14.650

6.  Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness.

Authors:  Cassandra L Krone; Anne L Wyllie; Josine van Beek; Nynke Y Rots; Anna E Oja; Mei Ling J N Chu; Jacob P Bruin; Debby Bogaert; Elisabeth A M Sanders; Krzysztof Trzciński
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Pneumococcal colonization in older adults.

Authors:  Susanna Esposito; Daniela Mari; Luigi Bergamaschini; Annalisa Orenti; Leonardo Terranova; Luca Ruggiero; Valentina Ierardi; Monia Gambino; Francesco Della Croce; Nicola Principi
Journal:  Immun Ageing       Date:  2016-01-12       Impact factor: 6.400

8.  Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in Sicily.

Authors:  Fabio Tramuto; Emanuele Amodio; Giuseppe Calamusa; Vincenzo Restivo; Claudio Costantino; Francesco Vitale
Journal:  Int J Mol Sci       Date:  2017-01-06       Impact factor: 5.923

9.  Community-acquired pneumonia caused by carbapenem-resistant Streptococcus pneumoniae: re-examining its prevention and treatment.

Authors:  Asako Doi; Kentaro Iwata; Hiroshi Takegawa; Kanji Miki; Yumi Sono; Hiroaki Nishioka; Jumpei Takeshita; Keisuke Tomii; Tsunekazu Haruta
Journal:  Int J Gen Med       Date:  2014-05-21

Review 10.  Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination.

Authors:  Andrea Orsi; Filippo Ansaldi; Cecilia Trucchi; Roberto Rosselli; Giancarlo Icardi
Journal:  Int J Mol Sci       Date:  2016-07-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.